Maegan,

I recently looked into this myself. According to the Federal Funding Accountability and Transparency Act Subaward Reporting System website, https://www.fsrs.gov/#a-faqs, under FAQs, "if the initial award is below $30,000 but subsequent grant modifications result in a total award equal to or over $30,000, the award will be subject to the reporting requirements, as of the date the award exceeds $30,000."

Best,

Sydney

Sydney Pack, MHA
Grants and Contracts Officer, Research Administration
Allegheny Singer Research Institute D/B/A AHN Research Institute
Allegheny Health Network

Tel 412-330-6142
Cell 870-703-7717
xxxxxx@ahn.org

-----Original Message-----
From: xxxxxx@lists.healthresearch.org [mailto:xxxxxx@lists.healthresearch.org] On Behalf Of Bobbie Ursin
Sent: Thursday, October 28, 2021 1:05 PM
To: 'xxxxxx@lists.healthresearch.org' <xxxxxx@lists.healthresearch.org>
Subject: [EXTERNAL] Re: [RESADM-L] FFATA on Incremental Subawards

WARNING:  This email originated from an external source and could contain harmful links or attachments.  Use extreme caution.  Report this to xxxxxx@ahn.org if you suspect this is a harmful email.

Meagan,

I would say don't mark it, until you do a subsequent amendment authorizing funding, which does meet the reporting threshold.

Bobbie Ursin
________________________________________
From: xxxxxx@lists.healthresearch.org <xxxxxx@lists.healthresearch.org> on behalf of McKerrow, Maegan <xxxxxx@SHSU.EDU>
Sent: Thursday, October 28, 2021 9:57:30 AM
To: 'xxxxxx@lists.healthresearch.org'
Subject: [RESADM-L] FFATA on Incremental Subawards

Good morning,

When issuing a subaward using the FDP templates and the cumulative total of the subaward doesn't reach the FFATA threshold until year 2 should you mark that it is subject to FFATA review in year one? It seems like a simple question but I am stuck on it.

Any thoughts would be greatly appreciated.

Thank you.

Maegan

- = - = - = - = - = - = -

This email was sent to xxxxxx@NAU.EDU via the Research Administrator's mailing list.

To unsubscribe from RESADM-L, go to https://secure-web.cisco.com/18io9krddP_Vj20IV1xMYDjsSqISwsa95qw3J52ZyBtUIDqcK9hm8YVYSxyxSIFseAtN-j1rDKrWMndwPlu3o3mwABJimb7WDAAY6XC3SPBvxOehxH4CyX5aV6Z0OwrzOwl6t55OGDOBdRPLbp9Cd9JOZWgDhG9Od-moZhYH0pXbsgWFd89eKQsZHtS0K1iOVeRi2HyfXyWc22JKeRfM-XbX_2Ks3twI6vb3Bgd3i4NHTnelYbKbudhptew24wPyFVZh9Who6na-e09b8AOEVXoei1XQV9o9yEWbG4mfPeLwrNcczvlGkjx8V7rsz5NN-/https%3A%2F%2Flists.healthresearch.org and go into the Account Settings area.

List archives are available at: https://secure-web.cisco.com/1-oPbbNtDGbw9B6SVkd5lm6u_T4aJIwlAi8NqNnEYZ9_y6gEqUtVKg5JwAuRenfNpSDHHBsXdHrjdE6zHieCAB1o-43_9463SXrCgeCKcr114xl5sJEZfviXmnd9aB3YMiVZL_w8G_eJXvuVWzOzURgVFeG8Knaa320SwomUoYPRBNnxBPIg5JY2_eJiCpi9D9BSi-ITw-F4LHZWN881owAvlzGy4CmZgJeLtH3W7I0Adnq_6JiiN2OZ9kaKs1ZLhnj0dPEhSqNv1p7_iZWBPCr4bRHFKrT39C1L1qZlg493U5vrhYaM7DF5LEFWXH2Bz/https%3A%2F%2Flists.healthresearch.org%2Fresadm-l

To change your settings (such as Digest Mode or to temporarily suspend list emails): https://secure-web.cisco.com/18io9krddP_Vj20IV1xMYDjsSqISwsa95qw3J52ZyBtUIDqcK9hm8YVYSxyxSIFseAtN-j1rDKrWMndwPlu3o3mwABJimb7WDAAY6XC3SPBvxOehxH4CyX5aV6Z0OwrzOwl6t55OGDOBdRPLbp9Cd9JOZWgDhG9Od-moZhYH0pXbsgWFd89eKQsZHtS0K1iOVeRi2HyfXyWc22JKeRfM-XbX_2Ks3twI6vb3Bgd3i4NHTnelYbKbudhptew24wPyFVZh9Who6na-e09b8AOEVXoei1XQV9o9yEWbG4mfPeLwrNcczvlGkjx8V7rsz5NN-/https%3A%2F%2Flists.healthresearch.org

- = - = - = - = - = - = -
This email was sent to xxxxxx@AHN.ORG via the Research Administrator's mailing list.
To unsubscribe from RESADM-L, go to https://secure-web.cisco.com/18io9krddP_Vj20IV1xMYDjsSqISwsa95qw3J52ZyBtUIDqcK9hm8YVYSxyxSIFseAtN-j1rDKrWMndwPlu3o3mwABJimb7WDAAY6XC3SPBvxOehxH4CyX5aV6Z0OwrzOwl6t55OGDOBdRPLbp9Cd9JOZWgDhG9Od-moZhYH0pXbsgWFd89eKQsZHtS0K1iOVeRi2HyfXyWc22JKeRfM-XbX_2Ks3twI6vb3Bgd3i4NHTnelYbKbudhptew24wPyFVZh9Who6na-e09b8AOEVXoei1XQV9o9yEWbG4mfPeLwrNcczvlGkjx8V7rsz5NN-/https%3A%2F%2Flists.healthresearch.org and go into the Account Settings area.
List archives are available at:  https://secure-web.cisco.com/1-oPbbNtDGbw9B6SVkd5lm6u_T4aJIwlAi8NqNnEYZ9_y6gEqUtVKg5JwAuRenfNpSDHHBsXdHrjdE6zHieCAB1o-43_9463SXrCgeCKcr114xl5sJEZfviXmnd9aB3YMiVZL_w8G_eJXvuVWzOzURgVFeG8Knaa320SwomUoYPRBNnxBPIg5JY2_eJiCpi9D9BSi-ITw-F4LHZWN881owAvlzGy4CmZgJeLtH3W7I0Adnq_6JiiN2OZ9kaKs1ZLhnj0dPEhSqNv1p7_iZWBPCr4bRHFKrT39C1L1qZlg493U5vrhYaM7DF5LEFWXH2Bz/https%3A%2F%2Flists.healthresearch.org%2Fresadm-l
To change your settings (such as Digest Mode or to temporarily suspend list emails):   https://secure-web.cisco.com/18io9krddP_Vj20IV1xMYDjsSqISwsa95qw3J52ZyBtUIDqcK9hm8YVYSxyxSIFseAtN-j1rDKrWMndwPlu3o3mwABJimb7WDAAY6XC3SPBvxOehxH4CyX5aV6Z0OwrzOwl6t55OGDOBdRPLbp9Cd9JOZWgDhG9Od-moZhYH0pXbsgWFd89eKQsZHtS0K1iOVeRi2HyfXyWc22JKeRfM-XbX_2Ks3twI6vb3Bgd3i4NHTnelYbKbudhptew24wPyFVZh9Who6na-e09b8AOEVXoei1XQV9o9yEWbG4mfPeLwrNcczvlGkjx8V7rsz5NN-/https%3A%2F%2Flists.healthresearch.org

Confidentiality Notice:  This e-mail message and any attachments are intended solely for the individual or individuals designated above. It may contain confidential or proprietary information and may be subject to confidentiality protections and may be legally privileged.  If you are not the intended recipient, you are not authorized to read, copy, retain or distribute this message.  If you receive this message in error, please immediately notify the sender by reply e-mail and delete this message. The sender does not waive any privilege or right of privacy or confidentiality that may attach to this communication. You are not authorized to read, copy, retain, or  distribute this message, or disclose its contents to any other person. Thank you.